CCN3 suppresses mitogenic signalling and reinstates growth control mechanisms in Chronic Myeloid Leukaemia

Journal of Cell Communication and Signaling

Volumn 6, Issue 1, 2012, Pages 27-35

  McCallum, Lynn ^a   Lu, Wanhua ^b   Price, Susan ^b   Lazar, Noureddine ^c   Perbal, Bernard ^d   Irvine, Alexandra E ^b  

^a UNIVERSITY OF PLYMOUTH   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d L'Oreal R and D   (United States)

Author keywords

AKT; BCR ABL; CCN3; ERK; Imatinib; Integrin; Signalling

Indexed keywords

ALPHA6 INTEGRIN; BETA4 INTEGRIN; IMATINIB; LIPOCORTIN 5; NEPHROBLASTOMA OVEREXPRESSED PROTEIN; RECOMBINANT PROTEIN; RECOMBINANT PROTEIN CCN3; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL ADHESION; CELL COUNT; CELL CYCLE G0 PHASE; CELL KILLING; CELL STRAIN K 562; CHRONIC MYELOID LEUKEMIA; COLONY FORMATION; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MITOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 82455197902     PISSN: 18739601     EISSN: 1873961X     Source Type: Journal    
DOI: 10.1007/s12079-011-0142-2     Document Type: Article

References (27)

1. Bhatia R, Munthe HA, Verfaillie CM (1999) Role of abnormal integrin-cytoskeletal interactions in impaired beta1 integrin function in chronic myelogenous leukemia hematopoietic progenitors. Exp Hematol 27(9):1384-1396 (Pubitemid 29409457)
2. Borland G, Cushley W (2004) Positioning the immune system: unexpected roles for alpha6-integrins. Immunology 111(4):381-383 (Pubitemid 38482488)
3. Chevalier G, Yeger H, Martinerie C, Laurent M, Alami J, Schofield PN, Perbal B (1998) novH: differential expression in developing kidney and Wilm's tumors. Am J Pathol 152(6):1563-1575 (Pubitemid 28275014)
4. Deininger MW, Holyoake TL (2005) Can we afford to let sleeping dogs lie? Blood 105(5):1840-1841 (Pubitemid 40731754)
5. Deininger MW, Goldman JM, Melo JV (2000) The molecular biology of chronic myeloid leukemia. Blood 96(10):3343-3356
6. De Pereda JM, Lillo MP, Sonnenberg A (2009) Structural basis of the interaction between integrin alpha6beta4 and plectin at the hemidesmosomes. EMBO J 28(8):1180-1190
7. Fu CT, Bechberger JF, Ozog MA, Perbal B, Naus CC (2004) CCN3 (NOV) interacts with connexin43 in C6 glioma cells: possible mechanism of connexin-mediated growth suppression. J Biol Chem 279(35):36943-36950 (Pubitemid 39129044)
8. Fukunaga-Kalabis M, Martinez G, Liu ZJ, Kalabis J, Mrass P, Weninger W, Firth SM, Planque N, Perbal B, Herlyn M (2006) CCN3 controls 3D spatial localization of melanocytes in the human skin through DDR1. J Cell Biol 175(4):563-569 (Pubitemid 44790610)
9. Fukunaga-Kalabis M, Martinez G, Telson SM, Liu ZJ, Balint K, Juhasz I, Elder DE, Perbal B, Herlyn M (2008) Downregulation of CCN3 expression as a potential mechanism for melanoma progression. Oncogene 27(18):2552-2560 (Pubitemid 351550875)
10. Ginzinger DG (2002) Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. Exp Hematol 30(6):503-512 (Pubitemid 34626648)
11. Heaney NB, Holyoake TL (2007) Therapeutic targets in chronic myeloid leukaemia. Hematol Oncol 25(2):66-75 (Pubitemid 46972833)
12. Holbourn KP, Acharya KR, Perbal B (2008) The CCN family of proteins: structure-function relationships. Trends Biochem Sci 33 (10):461-473
13. Jorgensen HG, Holyoake TL (2001) A comparison of normal and leukemic stem cell biology in Chronic Myeloid Leukemia. Hematol Oncol 19(3):89-106
14. Lu W, McCallum L, Irvine AE (2009) A rapid and sensitive method for measuring cell adhesion. J Cell Comm Signal 3(2):147-149
15. Maillard M, Cadot B, Ball RY, Sethia K, Edwards DR, Perbal B, Tatoud R (2001) Differential expression of the ccn3 (nov) proto-oncogene in human prostate cell lines and tissues. Mol Pathol: MP 54(4):275-280 (Pubitemid 32730406)
16. Martinerie C, Gicquel C, Louvel A, Laurent M, Schofield PN, Le Bouc Y (2001) Altered expression of novH is associated with human adrenocortical tumorigenesis. J Clin Endocrinol Metab 86 (8):3929-3940 (Pubitemid 32756000)
17. McCallum L, Irvine AE (2009) CCN3 - a key regulator of the hematopoietic compartment. Blood Rev 23(2):79-85
18. McCallum L, Price S, Planque N, Perbal B, Pierce A, Whetton AD, Irvine AE (2006) A novel mechanism for BCR-ABL action: stimulated secretion of CCN3 is involved in growth and differentiation regulation. Blood 108(5):1716-1723 (Pubitemid 44316142)
19. McCallum L, Lu W, Price S, Lazar N, Perbal B, Irvine AE (2009) CCN3: a key growth regulator in Chronic Myeloid Leukaemia. J Cell Comm Signal 3(2):115-124
20. Perbal B, Zuntini M, Zambelli D, Serra M, Sciandra M, Cantiani L, Lucarelli E, Picci P, Scotlandi K (2008) Prognostic value of CCN3 in osteosarcoma. Clin Canc Res 14(3):701-709 (Pubitemid 351231150)
21. Perbal B, Lazar N, Zambelli D, Lopez-Guerrero JA, Llombart-Bosch A, Scotlandi K, Picci P (2009) Prognostic relevance of CCN3 in Ewing sarcoma. Hum Pathol 40(10):1479-1486
22. Sattler M, Salgia R (1998) Role of the adapter protein CRKL in signal transduction of normal hematopoietic and BCR/ABL-trans-formed cells. Leukemia 12(5):637-644 (Pubitemid 28220814)
23. Sin WC, Bechberger JF, Rushlow WJ, Naus CC (2008) Dose-dependent differential upregulation of CCN1/Cyr61 and CCN3/NOV by the gap junction protein Connexin43 in glioma cells. J Cell Biochem 103(6):1772-1782 (Pubitemid 351501909)
24. Streuli CH, Akhtar n (2009) Signal co-operation between integrins and other receptor systems. Biochem J 418(3):491-506
25. Verfaillie CM (1998) Adhesion receptors as regulators of the hematopoietic process. Blood 92(8):2609-2612 (Pubitemid 28469071)
26. Verfaillie CM, Hurley R, Zhao RC, Prosper F, Delforge M, Bhatia R (1997) Pathophysiology of CML: do defects in integrin function contribute to the premature circulation and massive expansion of the BCR/ABL positive clone? J Lab Clin Med 129(6):584-591 (Pubitemid 27288660)
27. Wong S, Witte ON (2001) Modelling Philadelphia chromosome positive leukemias. Oncogene 20(40):5644-5659 (Pubitemid 32928104)